The rules of your market have changed. How will you adapt?
With patent lengths decreasing, new pricing regulations emerging and global supply chains still recovering from the disruption caused by COVID-19, it’s never been harder to maximise the value and profitability of blockbuster drugs.
Today’s Life Sciences leaders are facing a vast array of challenges. To overcome them, they must:
- Bring new blockbuster drugs to market quickly and effectively to extend the total value generated by a drug before it reaches its patent cliff
- Navigate crowded global supply markets for Active Pharmaceutical Ingredients and accurately assess which suppliers can meet their needs
- Keep materials costs low to mitigate the impact of decreasing R&D returns and shift towards a strategy of cost control for profit maximisation
- Identify innovation opportunities quickly and move fast to make the most of emerging drug, supply chain and promotion opportunities
- Stay ahead of numerous regulatory changes and pressures impacting everything from drug lifecycle length to how drugs are priced
Here's how we can help
Control costs and optimise your supplier base with ease
The Smart Cube’s dedicated team of category and procurement experts can help you:
- Make sense of your data and integrate and augment it with valuable third-party data sets to extend category, commodity and patient understanding
- Master new categories at speed as new Active Pharmaceutical Ingredients emerge and create new opportunities for drug innovation
- Anticipate regulatory change and make proactive changes to your strategies to mitigate compliance and operational risks
- Make better-informed supplier decisions and identify which suppliers can best meet your needs in increasingly crowded global markets
Category Intelligence
Procurement teams are challenged by increasingly volatile supply markets and continued pressure to cut costs. But with huge swathes of unreliable public information and diverse datasets from procurement and finance systems, it is harder than ever to build and optimise effective category strategies, and identify valuable opportunities.
Find out more>
Commodity Intelligence
Commodity market volatility in pricing, supply and demand has a direct and significant impact on your organisation’s procurement budget, ability to deliver savings and overall profitability. The trouble is, many commodity markets are exactly that – volatile.
Find out more>
Supplier Risk Intelligence
For businesses with a large supplier base and complex supply chains, managing risks is a major challenge. A staggering 95% of businesses responding to The Smart Cube’s recent risk survey state they struggle to detect risks well in advance of their occurrence. Not only are they exposed to wide-ranging risks associated with suppliers but also risks relating to the broader supply markets and geographies. As a result, an increasing number of companies are experiencing disruptions due to issues with their tier 1 and sub-tier suppliers.
Find out more>
Procurement Analytics
Modern procurement teams are faced with managing fast-evolving demand-supply situations, disruptive trends and a multitude of vendors, however diverse information sources often result in conflicting indicators.
Find out more>Make blockbuster drugs do more
The Smart Cube’s Commercial, Sales and Marketing solutions can help you:
- Uncover how, where, when and why your drugs are being purchased and prescribed across diverse user groups and geographies
- Empower your teams with deep analytical insights and enable them to make stronger pricing and promotion decisions at speed
- Identify new drug opportunities and make better-informed pricing and promotion decisions across your drug portfolio
- Optimise your marketing efforts at every stage of the drug lifecycle to ensure maximum profitability before patent cliffs arrive
Analytics Centre of Excellence (CoE)
Today, most organisations have started their journey with analytics – but few have been able to realise its full value and scale up to support the entire business.
Find out more>
Commercial Growth Analytics
Delivering significant, sustainable revenue growth, while maximising profits, is always a challenge. But with consumer habits changing, regulatory standards becoming increasingly complex, and transformational channels evolving faster than ever before, making the right decisions at the right time has never been more important.
Find out more>
Consumer and Market Insights
Identifying ‘where to play’ and ‘how to win’ to drive successful growth strategies has always been complex. But with new business models and products, increasing price pressures, and changing customer behaviours to keep up with, the continuous monitoring of developments across the market has never been more important.
Find out more>
Pharma Marketing Effectiveness
Pharmaceutical companies face unique challenges when it comes to understanding customers, building informed and targeted brand and marketing strategies, and adopting a customer-centric go-to-market approach.
Find out more>Get the right insights into the right hands – fast
With Analytics and Digital Solutions from The Smart Cube, you can:
- Bring diverse data sets together and uncover the valuable insight trapped within siloed data sources across your organisation
- Harness the power of AI to accelerate insight delivery, support drug development and dive deeper into internal and third-party data sets than ever before
- Empower everyone with powerful insights through tailored dashboards, accessible through any device, at any time
- Optimise routes to market and make better-informed decisions on which carriers and transportation partners can best meet your unique demands
Analytics Centre of Excellence (CoE)
Today, most organisations have started their journey with analytics – but few have been able to realise its full value and scale up to support the entire business.
Find out more>
Procurement Analytics
Modern procurement teams are faced with managing fast-evolving demand-supply situations, disruptive trends and a multitude of vendors, however diverse information sources often result in conflicting indicators.
Find out more>